ClinConnect ClinConnect Logo
Search / Trial NCT04304911

UP in Blended Format for Transdiagnostic Treatment of Emotional Disorders in the Spanish National Health System

Launched by INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN · Mar 9, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Emotional Disorder Unified Protocol Public Health Transdiagnostic Approach

ClinConnect Summary

This clinical trial is studying a new approach to treating emotional disorders, such as anxiety and depression, using a method called the Unified Protocol (UP). The goal is to see how effective this blended treatment is compared to the usual care patients receive in the Spanish National Health System. The study aims to find out not just how well this new method works, but also how much it costs and how easy it is to implement.

To participate in the trial, you need to be at least 18 years old, have been diagnosed with an emotional disorder, and be fluent in Spanish. You should also have access to a smartphone and be stable on any medications you may be taking for at least three months before the study starts. Participants will receive either the new blended treatment or the standard care, and they can expect to engage in therapy that combines in-person sessions with online support. It's important to note that individuals with more severe mental health issues or who have had extensive prior therapy may not be eligible for this study. If you think this trial might be right for you or someone you know, feel free to discuss it with a healthcare provider for more information.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Principal diagnosis of Emotional disorder (Evaluated by MINI interview)
  • The patient is over 18 years of age
  • The patient is fluent in the language in which the therapy is performed (Spanish in the present study)
  • To have a Smartphone
  • Patients taking pharmacological treatment for their ED will be asked to maintain the same dosages and medications for at least 3 months prior to enrolling in the study and during the whole treatment
  • The patient signs the informed consent form.
  • Exclusion Criteria:
  • The patient presents a severe condition that would require to be prioritized for treatment, these include a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder), suicide risk at the time of assessment, or substance use in the last three months
  • The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable Cognitive behavioral therapy (CBT) principles within the past 5 years.

About Instituto De Investigación Sanitaria Aragón

Instituto de Investigación Sanitaria Aragón (IIS Aragón) is a leading clinical research organization dedicated to advancing healthcare through innovative research and collaboration. Based in Spain, IIS Aragón focuses on translational medicine, bridging the gap between laboratory discoveries and clinical applications. The institute fosters a multidisciplinary approach, bringing together experts from various fields to enhance the quality and efficiency of clinical trials. With a commitment to ethical standards and patient safety, IIS Aragón plays a pivotal role in driving scientific advancements and improving health outcomes in the region and beyond.

Locations

Vinaròs, Comunidad Valenciana, Spain

Patients applied

0 patients applied

Trial Officials

Jorge Osma, Ph.D

Principal Investigator

Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials